Otelfingen, Switzerland

Philochem Ag


USPTO Granted Patents = 6

% Expired Patents = 16.7



Forward Citations = 71

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Dario Neri (4 out of 41 patents)

silverMedal Samuele Cazzamalli (2 out of 2 patents)

bronzeMedal Manuela Kaspar (1 out of 6 patents)

4.  Willy Decurtins (1 out of 3 patents)

5.  Raphael Franzini (1 out of 1 patent)

6.  Moreno Wichert (1 out of 3 patents)

7.  Jörg Scheuermann (1 out of 3 patents)

8.  Christoph Schliemann (1 out of 4 patents)

9.  Alessandra Villa (1 out of 2 patents)

10.  Christoph Dumelln (1 out of 1 patent)

11.  Gabriele Bassi (1 out of 1 patent)

12.  Sheila Plaza Dakhel (1 out of 1 patent)

13.  Etienne J Donckele (1 out of 1 patent)

14.  Florent Samain (1 out of 1 patent)

15.  Eleonore Schmidt (1 out of 1 patent)


6 patents:

Company Overview
Philochem Ag is a German-based company specializing in the synthesis of complex molecules for the pharmaceutical and agrochemical industries. With a focus on innovative, sustainable solutions, Philochem Ag provides custom synthesis services and offers a wide range of building blocks for drug discovery and development. Their team of experienced chemists and state-of-the-art facilities ensure high quality products and reliable services for their global clients.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#1 in Otelfingen

#1,483 in Switzerland

Otelfingen, CH
Otelfingen, Switzerland
Forward Citations = 71

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Philochem Ag. Retrieved from https://idiyas.com/company/philochem-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…